<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019737"><a href="http://purl.obolibrary.org/obo/MONDO_0019737">MONDO:0019737</a></h3>
<p><strong>Label:</strong> thrombotic microangiopathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012350">MONDO:0012350</a> (complement factor H deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0014005">MONDO:0014005</a> (immunoglobulin-mediated membranoproliferative glomerulonephritis), <a href="http://purl.obolibrary.org/obo/MONDO_0018896">MONDO:0018896</a> (thrombotic thrombocytopenic purpura), <a href="http://purl.obolibrary.org/obo/MONDO_0016244">MONDO:0016244</a> (atypical hemolytic-uremic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0009335">MONDO:0009335</a> (hemolytic uremic syndrome, atypical, susceptibility to, 1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_609814">OMIM:609814</a>, <a href="http://www.orpha.net/ORDO/Orphanet_329918">Orphanet:329918</a>, <a href="http://www.orpha.net/ORDO/Orphanet_329903">Orphanet:329903</a>, <a href="http://www.orpha.net/ORDO/Orphanet_357008">Orphanet:357008</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90038">Orphanet:90038</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2134">Orphanet:2134</a>, <a href="http://purl.obolibrary.org/obo/OMIM_235400">OMIM:235400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_93579">Orphanet:93579</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615008">OMIM:615008</a>, <a href="http://purl.obolibrary.org/obo/OMIM_274150">OMIM:274150</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612923">OMIM:612923</a>, <a href="http://www.orpha.net/ORDO/Orphanet_93581">Orphanet:93581</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612922">OMIM:612922</a>, <a href="http://www.orpha.net/ORDO/Orphanet_54370">Orphanet:54370</a>, <a href="http://www.orpha.net/ORDO/Orphanet_93571">Orphanet:93571</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612925">OMIM:612925</a>, <a href="http://www.orpha.net/ORDO/Orphanet_54057">Orphanet:54057</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612924">OMIM:612924</a>, <a href="http://www.orpha.net/ORDO/Orphanet_200421">Orphanet:200421</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612926">OMIM:612926</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001937">HP:0001937</a> (Microangiopathic hemolytic anemia) 72.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011873">HP:0011873</a> (Abnormal platelet count) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011873">HP:0011873</a> (Abnormal platelet count) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001873">HP:0001873</a> (Thrombocytopenia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001873">HP:0001873</a> (Thrombocytopenia) and <a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001872">HP:0001872</a> (Abnormality of thrombocytes) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001872">HP:0001872</a> (Abnormality of thrombocytes) and <a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0011895">HP:0011895</a> (Anemia due to reduced life span of red cells) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001878">HP:0001878</a> (Hemolytic anemia) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) and <a href="http://purl.obolibrary.org/obo/HP_0012100">HP:0012100</a> (Abnormal circulating creatinine level) 67.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004364">HP:0004364</a> (Abnormality of nitrogen compound homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0005575">HP:0005575</a> (Hemolytic-uremic syndrome) 67.50%</li>
</ul>
</body>
</html>
